Radiolabelling: Seeing Through The Mist
Is the parent drug as well as its associated metabolites adequately evaluated for safety in preclinical studies?
Dr Sean Kitson from Almac’s Radiolabelling and Biocatalysis Group gives an interpretation.
Is the parent drug as well as its associated metabolites adequately evaluated for safety in preclinical studies?
Dr Sean Kitson from Almac’s Radiolabelling and Biocatalysis Group gives an interpretation.